Mirae Asset Global Investments Co., Ltd. Pyxis Oncology, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $37.3 Billion
- Q1 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,990 shares of PYXS stock, worth $2,109. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,990
Previous 1,982
0.4%
Holding current value
$2,109
Previous $3,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PYXS
# of Institutions
99Shares Held
24.3MCall Options Held
993KPut Options Held
42.6K-
Laurion Capital Management LP New York, NY3.63MShares$3.84 Million0.11% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.98MShares$3.16 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$2.95 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.44MShares$2.59 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.08MShares$1.15 Million0.0% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $37.2M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...